CN107898949A - 一种治疗肺癌的中药制剂及其制备方法 - Google Patents

一种治疗肺癌的中药制剂及其制备方法 Download PDF

Info

Publication number
CN107898949A
CN107898949A CN201711109338.0A CN201711109338A CN107898949A CN 107898949 A CN107898949 A CN 107898949A CN 201711109338 A CN201711109338 A CN 201711109338A CN 107898949 A CN107898949 A CN 107898949A
Authority
CN
China
Prior art keywords
lung cancer
chinese medicine
ginseng
chinese
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201711109338.0A
Other languages
English (en)
Inventor
孙思远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Yichuang Biotechnology Co Ltd
Original Assignee
Sichuan Yichuang Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Yichuang Biotechnology Co Ltd filed Critical Sichuan Yichuang Biotechnology Co Ltd
Priority to CN201711109338.0A priority Critical patent/CN107898949A/zh
Publication of CN107898949A publication Critical patent/CN107898949A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/65Amphibians, e.g. toads, frogs, salamanders or newts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8888Pinellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明属于中药制剂领域,目的是根据中医治疗早期肺癌的认识机理而提供一种治疗肺癌的中药制剂,所述肺癌的各个组分及其质量份比如下:牛蒡子60~160g、三七30~100g、蟾皮50~100g、人参20~100g、无花果100~160g、五倍子30~70g、川贝母30~120g、血竭10~25g、黄芪150~300g、穿山甲30~90g、白果50~90g、薏苡仁100~350g、当归80~160g、法半夏30~100g、甘草30~100g;本发明提供的药物是一个很好的中药组方。

Description

一种治疗肺癌的中药制剂及其制备方法
技术领域
本发明属于中药制剂领域,具体涉及一种治疗肺癌的中药制剂,特别是供肺癌患者使用的中药制剂及其制备方法的领域。
背景技术
医者认为:肺癌是发病率和死亡率增长最快,对人群健康和生命威胁最大的恶性肿瘤之一。近50年来许多国家都报道肺癌的发病率和死亡率均明显增高,男性肺癌发病率和死亡率均占所有恶性肿瘤的第一位,女性发病率占第二位,死亡率占第二位。肺癌的病因至今尚不完全明确,大量资料表明,长期大量吸烟与肺癌的发生有非常密切的关系。已有的研究证明:长期大量吸烟者患肺癌的概率是不吸烟者的10~20倍,开始吸烟的年龄越小,患肺癌的几率越高。此外,吸烟不仅直接影响本人的身体健康,还对周围人群的健康产生不良影响,导致被动吸烟者肺癌患病率明显增加。城市居民肺癌的发病率比农村高,这可能与城市大气污染和烟尘中含有致癌物质有关。
那么,就如何找到一种可有效治疗肺癌的中药组合物,是本领域技术人员亟待要解决的问题。
发明内容
随着我国中医中药学的不断发展,在治疗肺癌上,人们逐渐意识到了中医治疗肺癌的优点,且在治疗过程中疗效好、见效快、毒副作用小等优势,针对现有西医治疗肺癌的现状,本发明的目的是在于提供一种治疗肺癌的中药制剂,以解决肺癌患者早日恢复健康和延长生存期的问题。该药物是以常见的中药为原料,通过选择合理的药物及质量份比,可有效治疗上述肺癌一证。
为达到上述发明的目的,本发明所采用的技术方案为:提供一种治疗肺癌的中药制剂及其制备方法,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子60~160g、三七30~100g、蟾皮50~100g、人参20~100g、无花果100~160g、五倍子30~70g、川贝母30~120g、血竭10~25g、黄芪150~300g、穿山甲30~90g、白果50~90g、薏苡仁100~350g、当归80~160g、法半夏30~100g、甘草30~100g,辅料:淀粉适量。
一种治疗肺癌的中药制剂及其制备方法,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子70~140g、三七38~90g、蟾皮58~90g、人参26~90g、无花果115~140g、五倍子38~60g、川贝母38~105g、血竭12~22g、黄芪180~260g、穿山甲38~80g、白果58~80g、薏苡仁115~310g、当归90~140g、法半夏38~90g、甘草38~90g,辅料:淀粉适量。
一种治疗肺癌的中药制剂及其制备方法,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子120g、三七80g、蟾皮80g、人参80g、无花果120g、五倍子52g、川贝母95g、血竭20g、黄芪230g、穿山甲70g、白果70g、薏苡仁260g、当归120g、法半夏80g、甘草80g,辅料:淀粉适量。
一种治疗肺癌的中药制剂及其制备方法,其特征在于,所述方法包括如下步骤制备而成:
A、将上述所有原料中药拣去杂质和粉尘后,按照质量份比分别粉碎成粗粒状包煎;
B、将包好的原料中药放入冷开水中浸泡45min后,再将浸泡好的药物放入砂锅内煎煮三次:①加水量为药材总量的9~10倍,先进行武火煎煮,待煎煮到15min时,转文火熬制115min,滤取药液;②加水量为干药渣总量的8~9 倍,先进行武火煎煮,待煎煮到10min时,转文火熬制105 min,滤取药液;③加水量为干药渣总量的7~8 倍,先进行武火煎煮,待煎煮到8min时,转文火熬制90 min,滤取药液;④合并三次药液,并减压浓缩至每毫升含生药3g的标准后,即得到药物浸膏。
C、将上述B中制备好的浸膏干燥、消毒,并按照质量份比共研为极细末备用;
D、按照传统的常规工艺及辅料制备中药胶囊剂的方法,将C中研磨好的极细末药物过筛后,和辅料一并放入药器中混合均匀,然后制备成胶囊剂(其胶囊锁合后的总长度为23.3mm,药粉容量0.4~0.5g/粒),继而抛光、消毒,分装密封即得。
一种治疗肺癌的中药制剂及其制备方法,其特征在于,所述服用方法为:将制备好的胶囊剂药物以每日三次服用,早中晚各服一次,给药量2.5g(5粒)/次,饭后半小时温开水送服。30天为一个疗程,服药5个疗程,症状基本消失,生存期达一年以上。
本发明组方中的各原料中药在中国药典、中国辞典以及中华本草中均有详细的记载。本发明选用其中最常见的中药为原料,充分发挥各组分的药理功效:
牛蒡子,性味:辛、苦、寒,具有疏散风热、宣肺利咽、解毒透疹、消肿疗疮之功效,用于治疗风热感冒、温病初起、麻疹不透、痈肿疮毒等症;
三七,性味:甘、苦、微温,具有止血、散瘀、定通、消肿之功效,用于治疗刀伤、枪伤及跌扑创伤出血不止,又可治吐血、衄血、便血、尿血、血痢、血崩、经水不止、产后恶血不下、血晕、血痛、目赤通肿、兽咬蛇伤等症;
蟾皮,性味:辛、凉,具有微毒清热解毒、利水消胀之功效,用于治疗痈疽、肿毒、瘰疬、肿瘤、疳积腹胀、慢性气管炎;
人参,性味:甘、微苦、温,具有补气固脱,补肺益脾,生津,安神,益智之功效,用于治疗补气救脱、益心复脉、安神、生津、补肺、健脾等功能,对于治疗心血管疾病、胃和肝脏疾病、糖尿病、不同类型的神经衰弱症、各种精神病、阳痿及某些癌症等均有较好疗效,亦是一种滋补强壮药;
无花果,性味:味甘、性凉,具有清热生津、健脾开胃、解毒消肿之功效,用于治疗咽喉肿痛、燥咳声嘶、乳汁稀少、肠热便秘、食欲不振、消化不良、泄泻、痢疾、痈肿、癣疾等症;
五倍子,性味:味酸、涩、性寒,具有敛肺降火、涩肠止泻、敛汗、止血、收湿敛疮之功效,用于治疗肺虚久咳、肺热痰嗽、久泻久痢、自汗盗汗、消渴、便血痔血、外伤出血、痈肿疮毒、皮肤湿烂;
川贝母,性味:味苦、甘,性微寒,具有清热润肺、化痰止咳、散结消痈之功效,用于治疗肺热燥咳、干咳少痰、阴虚劳嗽、痰中带血、瘰疬、乳痈、肺痈等症;
血竭,性味:甘、咸、平,具有活血定痛、化瘀止血、敛疮生肌之功效,用于治疗跌打损伤、心腹瘀痛、外伤出血、疮疡不敛;
黄芪,性味:甘、微温,具有补气固表、利尿托毒、排脓、敛疮生肌之功效,用于治疗气虚乏力、食少便溏、中气下陷、久泻脱肛、便血崩漏、表虚自汗、气虚水肿、痈疽难溃、久溃不敛、血虚痿黄、内热消渴、慢性肾炎蛋白尿、糖尿病等症;
穿山甲,性味:咸、凉,大毒,具有活血散结、通经下乳、消痈溃坚之功效,用于治疗血瘀经闭、症瘕、风湿痹痛、乳汁不下、痈肿、瘰疬,用于经闭癓瘕、乳汁不通、痈肿疮毒、关节痹痛、麻木拘挛;
白果,性味:性平、味甘、苦、涩,有毒,具有敛肺定喘、止带浊、缩小便之功效,用于治疗哮喘痰嗽、带下、白浊、小便频数、遗尿等症;
薏苡仁,性味:甘、淡、微寒,具有利湿健脾、舒筋除痹、清热排脓之功效,用于治疗水肿、脚气、小便淋沥、湿温病、泄泻带下、风湿痹痛、筋脉拘挛、肺痈、肠痈、扁平疣等症;
当归,性味:味甘、辛、微苦、性温,具有补血和血、调经止痛、润燥滑肠之功效,用于治疗***、经闭腹痛、癥瘕结聚、崩漏、血虚头痛、眩晕、痿痹、肠燥便难、赤痢后重,痈疽疮窃、跌扑损伤等病症;
法半夏,性味:辛、温,具有燥湿化痰之功效,用于治疗痰多咳喘、痰饮眩悸、风痰眩晕、痰厥头痛等症;
甘草,性味:甘、平,具有益气补中、缓急止痛、润肺止咳、泻火解毒、调和诸药之功效,用于治疗倦怠食少、肌瘦面黄、心悸气短、腹痛便溏、四肢挛急疼痛、脏躁、咳嗽气喘、咽喉肿痛、痈疮肿痛、小儿胎毒及药物、食物中毒。
本发明药物是基于中医治疗肺癌的原则,从依据肺癌的病理机制及药理作用认为:就肺癌,本发明所提供的药物中的各原料中药药效共奏,对上述疾病有很好的治疗效果。
具体实施方式
本发明就是针对上述肺癌的治疗而提出的一种中药配方,采用该配方制备的药物药效好,见效快,是一个很好的中药组方,特别适合临床使用。下面结合本发明的具体实施方式作进一步详细的描述:
实施例1:
一种治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子120g、三七80g、蟾皮80g、人参80g、无花果120g、五倍子52g、川贝母95g、血竭20g、黄芪230g、穿山甲70g、白果70g、薏苡仁260g、当归120g、法半夏80g、甘草80g,辅料:淀粉适量。
实施例2:
一种治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子140g、三七90g、蟾皮90g、人参90g、无花果140g、五倍子60g、川贝母105g、血竭22g、黄芪260g、穿山甲80g、白果80g、薏苡仁310g、当归140g、法半夏90g、甘草90g,辅料:淀粉适量。
实施例3:
一种治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及质量份比如下所示:
牛蒡子160g、三七100g、蟾皮100g、人参100g、无花果160g、五倍子70g、川贝母120g、血竭25g、黄芪300g、穿山甲90g、白果90g、薏苡仁350g、当归160g、法半夏100g、甘草100g,辅料:淀粉适量。
典型病例:
经临床诊断治疗肺癌患者共1273例,年龄为63岁以上的736例,只有537例为63岁以下。1273例患者中痊愈和延长生存期的有293例,有效的535例,无效的445例。总有效率达65%。

Claims (3)

1.一种治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及其质量份比如下所示:
牛蒡子60~160g、三七30~100g、蟾皮50~100g、人参20~100g、无花果100~160g、五倍子30~70g、川贝母30~120g、血竭10~25g、黄芪150~300g、穿山甲30~90g、白果50~90g、薏苡仁100~350g、当归80~160g、法半夏30~100g、甘草30~100g,辅料:淀粉适量。
2.根据权利要求1所述的治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及其质量份比如下所示:
牛蒡子70~140g、三七38~90g、蟾皮58~90g、人参26~90g、无花果115~140g、五倍子38~60g、川贝母38~105g、血竭12~22g、黄芪180~260g、穿山甲38~80g、白果58~80g、薏苡仁115~310g、当归90~140g、法半夏38~90g、甘草38~90g,辅料:淀粉适量。
3.根据权利要求1至2所述的治疗肺癌的中药制剂,其特征在于,所述中药制剂的各个组分及其质量份比如下所示:
牛蒡子120g、三七80g、蟾皮80g、人参80g、无花果120g、五倍子52g、川贝母95g、血竭20g、黄芪230g、穿山甲70g、白果70g、薏苡仁260g、当归120g、法半夏80g、甘草80g,辅料:淀粉适量。
CN201711109338.0A 2017-11-11 2017-11-11 一种治疗肺癌的中药制剂及其制备方法 Withdrawn CN107898949A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711109338.0A CN107898949A (zh) 2017-11-11 2017-11-11 一种治疗肺癌的中药制剂及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711109338.0A CN107898949A (zh) 2017-11-11 2017-11-11 一种治疗肺癌的中药制剂及其制备方法

Publications (1)

Publication Number Publication Date
CN107898949A true CN107898949A (zh) 2018-04-13

Family

ID=61845105

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711109338.0A Withdrawn CN107898949A (zh) 2017-11-11 2017-11-11 一种治疗肺癌的中药制剂及其制备方法

Country Status (1)

Country Link
CN (1) CN107898949A (zh)

Similar Documents

Publication Publication Date Title
CN105288462A (zh) 一种可有效治疗胃癌的中药组合物及其制备方法
CN107898949A (zh) 一种治疗肺癌的中药制剂及其制备方法
CN103784851B (zh) 一种治疗美尼尔氏综合症的中药制剂及制备方法
CN106692821A (zh) 一种治疗神经外科术后头痛的中药制剂
CN105999060A (zh) 一种治疗妇女血瘀型癥瘕的中药组合物及其制备方法
CN104984149B (zh) 一种与放疗配合使用的药物
CN107929574A (zh) 一种用于治疗肺癌的内服药物及其制备方法
CN107929614A (zh) 一种治疗乳腺癌的内服中药丸及制备方法
CN107753858A (zh) 一种用于治疗中期肺癌的胶囊剂药物及制备方法
CN107753711A (zh) 一种治疗早期肺癌的丸剂药物及制备方法
CN107875345A (zh) 一种治疗肺癌的中药制剂及其制备方法
CN107823368A (zh) 一种治疗乳腺癌的胶囊剂药物及其制备方法和应用
CN107854655A (zh) 一种可有效治疗中晚期肺癌的中药组合物
CN103341054A (zh) 一种治疗心脑血管疾病的中药制剂及制备方法
CN107753909A (zh) 一种治疗小儿咳嗽的内服药物及制备方法
CN107714870A (zh) 一种可有效治疗支气管哮喘的中药组合物
CN107802728A (zh) 一种治疗肺癌的胶囊剂药物及制备方法
CN107823553A (zh) 一种治疗乳腺癌的胶囊剂药物及制备方法
CN107854599A (zh) 一种治疗甲状腺癌的胶囊剂药物及制备方法
CN107469003A (zh) 一种治疗甲状腺癌术后气滞血瘀证的内服药物及制备方法
CN109646569A (zh) 一种治疗消渴症(糖尿病)的中药组合物,中药提取物及其制备方法和剂型
CN109833454A (zh) 一种预防高血压的中药
CN107802803A (zh) 一种用于治疗肺癌的内服药物及其制备方法
CN107753842A (zh) 一种用于治疗痛风的内服药物及制备方法
CN107812142A (zh) 一种可有效治疗痛风的丸剂药物及制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20180413

WW01 Invention patent application withdrawn after publication